• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CUV
Click for more information
1.36% $13.37

CLINUVEL PHARMACEUTICALS LIMITED - News & Media

Market Cap $669.5M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Clinuvel Pharmaceuticals Limited is an Australia-based global specialty pharmaceutical... Clinuvel Pharmaceuticals Limited is an Australia-based global specialty pharmaceutical company. The Company is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the USA, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). The Company’s pharmaceuticals product development includes PRENUMBRA and NEURACTHEL. Its PhotoCosmetics product development includes CYACELLE and DNA Repair Assist and Melanogenesis. PRENUMBRA is a formulation of afamelanotide designed to provide a flexible dose in identified patient groups. NEURACTHEL is a novel formulation of the melanocortin adrenocorticotropic hormone (ACTH).More

Articles & Videos

British study shows Clinuvel drug effective on DNA of UV-damaged skin

Clinuvel Pharmaceuticals Ltd has reported final results of its study of the efficacy of afamelanotide to repair the DNA of damaged skin.

05 Jul 2024 11:06 (AEST)



(20min delay)
Last
$13.37 		Change
0.180(1.36%) 		Mkt cap ! $669.5M
Open High Low Value Volume
$13.19 $13.59 $13.13 $1.181M 88.20K

Buyers (Bids)

No. Vol. Price($)
1 606 $13.31
 

Sellers (Offers)

Price($) Vol. No.
$13.51 282 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
Last
$13.37 		  Change
0.180 ( 1.23 %)
Open High Low Volume
$13.23 $13.61 $13.18 17074
Last updated 15.59pm 23/08/2024 ?
CUV (ASX) Chart

Top Stories

The business of sport: Warren Tredrea's take on this week's news

Former Port Adelaide AFL star – turned media personality – Warren Tredrea and co-host Jack Hudson explore money in sport.
Dale Gillham's weekly wrap: responding to a weak iron ore price with investing decisions Given the recent fall in iron ore prices below the $100 mark, now might be the time to buy into specialised stocks in the materials sector.
Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings A southward cluster of outcropping pegmatites on-site Chariot Corporation's (ASX:CC9) flagship Black Mountain hard rock lithium project has led management and geotechs to sign off on a promising future drilling target for the company as exploration on-site gathers pace.
Noronex kicks off EM survey at Humpback, Namibia – part of South32's earn-in deal to access Kalahari Copper Belt Noronex Limited (ASX:NRX) has kicked off a gravity EM survey at the Damara project in Namibia – part of its earn-in deal with South32.
How flooding did Strategic Energy Resources a favour: Four holes down in 'redesigned' gold & copper campaign Strategic Energy Resources is 4 holes into a 40-hole RC drill campaign at its Achilles 1 copper-gold target in the Cobar Basin of NSW.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.